Dear Reader,
I am pleased to announce our final agenda for the Fierce Biotech Virtual Series, Next Gen: What’s beyond the leading edge of biotech and pharma? This series will run virtually June 22-23, 2021.
We're looking for the next generation. New waves of cancer targets. Novel approaches to cell and gene therapies. Cutting-edge technologies set to change biopharma manufacturing. Even a new cohort of up-and-coming industry leaders.
We'll go beyond the cutting-edge panel discussions we are known for. We bring you CEO interviews, panel discussions and partner presentations exploring the next generation of drug development.
Agenda highlights include:
Monday, June 22:
Panel: What's next in gene therapy
Executive Interview: Dave Lennon, President, Novartis Gene Therapies
Executive Interview: Marcio Souza, CEO, Praxis Precision Medicines
Panel: What's the next target in oncology
Executive Interview: Mark Wildgust, Ph.D., Vice President, Global Medical Affairs, Oncology, Janssen
Tuesday, June 23:
Panel: New trends shaping biopharma manufacturing
Executive Interview: Sebastian Guth, Ph.D., President, Americas Region, Bayer Pharmaceuticals and Brian Cantwell, Vice President, Digital Strategy, Bayer US Pharmaceuticals
Executive Interview: Ardy Arianpour, CEO and Co-Founder, Seqster
Panel: Who's next in biotech and pharma?
We'll have a strong focus on networking this year and will facilitate one to one meetings and groups chats with speakers, partners and attendees. I hope you can join us. Click here to reserve your seat today.
 | Rebecca Willumson |